Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

Jiaojiao Hao(Dalian Medical University), Wuguo Deng(Guangzhou University of Chinese Medicine)
Journal of Experimental & Clinical Cancer Research
February 4, 2019
Cited by 55


Related Papers